Tetrasiklin etkileşimleri

tetrasiklin antibiyotik sınıfından Tetrasiklin (Sumycin, Achromycin) için dizinlediğimiz FDA etiketlerinde ve bilgi sayfalarında 76 belgelenmiş etkileşim var: 19 majör, 28 orta, 26 minör ve bir etiketin anlamlı etkileşim olmadığını bildirdiği 3 çift. Aşağıdaki her kayıt, dayandığı cümleyi alıntılar. Bu ilaç sayfası bir başlangıç noktasıdır; sizin durumunuz için verilmiş bir hüküm değildir.

Etikete göre etkileşimler

Majör etkileşimler (19)

  • AdapalenretinoidMajör

    Concomitant use of isotretinoin and tetracycline should be avoided because isotretinoin, a systemic retinoid, is also known to cause pseudotumor cerebri. (Tetrasiklin etiketi, Uyarılar)

  • Amoksisilinpenisilin antibiyotikMajör

    Drug Interactions Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin or other bactericidal antibacterials. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Amoksisilin ve klavulanatpenisilin antibiyotikMajör

    Drug Interactions Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin or other bactericidal antibacterials. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Ampisilinpenisilin antibiyotikMajör

    Drug Interactions Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin or other bactericidal antibacterials. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Ampisilin ve sulbaktampenisilin antibiyotikMajör

    Drug Interactions Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin or other bactericidal antibacterials. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • AsitretinretinoidMajör

    Concomitant use of isotretinoin and tetracycline should be avoided because isotretinoin, a systemic retinoid, is also known to cause pseudotumor cerebri. (Tetrasiklin etiketi, Uyarılar)

  • BeksarotenretinoidMajör

    Concomitant use of isotretinoin and tetracycline should be avoided because isotretinoin, a systemic retinoid, is also known to cause pseudotumor cerebri. (Tetrasiklin etiketi, Uyarılar)

  • Demeklosiklintetrasiklin antibiyotikMajör

    CONTRAINDICATIONS This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines or any of the components of the product formulation. (Demeklosiklin etiketi, Kontrendikasyonlar)

  • Dikloksasilinpenisilin antibiyotikMajör

    Drug Interactions Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin or other bactericidal antibacterials. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Doksisiklintetrasiklin antibiyotikMajör

    Doxycycline hyclate are contraindicated in persons who have shown hypersensitivity to any of the tetracyclines. (Doksisiklin etiketi, Kontrendikasyonlar)

  • İzotretinoinretinoidMajör

    Concomitant use of isotretinoin and tetracycline should be avoided because isotretinoin, a systemic retinoid, is also known to cause pseudotumor cerebri. (Tetrasiklin etiketi, Uyarılar)

  • Minosiklintetrasiklin antibiyotikMajör

    EMROSI is contraindicated in patients with a history of hypersensitivity to any of the tetracyclines [see Warnings and Precautions (5.1) ]. (Minosiklin etiketi, Kontrendikasyonlar)

  • Nafsilinpenisilin antibiyotikMajör

    Drug Interactions Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin or other bactericidal antibacterials. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Oksasilinpenisilin antibiyotikMajör

    Drug Interactions Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin or other bactericidal antibacterials. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Penisilin Gpenisilin antibiyotikMajör

    Drug Interactions Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin or other bactericidal antibacterials. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Penisilin Vpenisilin antibiyotikMajör

    Drug Interactions Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin or other bactericidal antibacterials. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Piperasilin ve tazobaktampenisilin antibiyotikMajör

    Drug Interactions Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin or other bactericidal antibacterials. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Tigesiklintetrasiklin antibiyotikMajör

    Avoid use in patients with known hypersensitivity to tetracyclines. (Tigesiklin etiketi, Uyarılar ve önlemler)

  • TretinoinretinoidMajör

    Concomitant use of isotretinoin and tetracycline should be avoided because isotretinoin, a systemic retinoid, is also known to cause pseudotumor cerebri. (Tetrasiklin etiketi, Uyarılar)

Orta düzey etkileşimler (28)

  • ApiksabanantikoagülanOrta

    Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • ArgatrobanantikoagülanOrta

    Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • AtovakuonantimalaryalOrta

    • Concomitant administration of tetracycline reduces atovaquone concentrations; use caution when coadministering. (Atovakuon etiketi, İlaç etkileşimleri)

  • Atovakuon ve proguanilantimalaryalOrta

    • Tetracycline may reduce atovaquone concentrations; parasitemia should be closely monitored. (Atovakuon ve proguanil etiketi, İlaç etkileşimleri)

  • BivalirudinantikoagülanOrta

    Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • As with other antibacterial drugs, use of tetracycline hydrochloride may result in overgrowth of nonsusceptible organisms, including fungi. (Bizmut subsitrat, metronidazol ve tetrasiklin etiketi, Uyarılar ve önlemler)

  • ÇinkoVitamin ve mineralOrta

    Çinko, kinolon ve tetrasiklin antibiyotiklerin emilimini azaltır; antibiyotiği çinkodan en az iki saat önce veya dört ila altı saat sonra alın. (NIH Office of Dietary Supplements, Zinc)

  • DabigatranantikoagülanOrta

    Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • DemirVitamin ve mineralOrta

    Demir bu ilaçları bağırsakta bağlar ve emilimlerini azaltır; dozları ayrı zamanlarda alın. (NIH Office of Dietary Supplements, Iron)

  • EdoksabanantikoagülanOrta

    Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • EnoksaparinantikoagülanOrta

    Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • FondaparinuksantikoagülanOrta

    Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • GlimepiridsülfonilüreOrta

    …antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides,… (Glimepirid etiketi, İlaç etkileşimleri)

  • HeparinantikoagülanOrta

    Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • KalsiyumVitamin ve mineralOrta

    Kalsiyum bu ilaçları bağırsakta bağlar ve emilen miktarı keskin biçimde azaltabilir; dozları ayrı zamanlarda alın. (NIH Office of Dietary Supplements, Calcium)

  • Kalsiyum asetatfosfat bağlayıcıOrta

    Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (Kalsiyum asetat etiketi, İlaç etkileşimleri)

  • KinaprilACE inhibitörüOrta

    Tetracycline and other drugs that interact with magnesium Simultaneous administration of tetracycline with quinapril hydrochloride reduced the absorption of tetracycline by approximately 28% to 37%, possibly due to the high magnesium content in quinapril tablets. (Kinapril etiketi, İlaç etkileşimleri)

  • KininantimalaryalOrta

    Although tetracycline may be concomitantly administered with quinine sulfate, patients should be monitored closely for adverse reactions associated with quinine sulfate. (Kinin etiketi, İlaç etkileşimleri)

  • Kolestipolsafra asidi bağlayıcıOrta

    The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride. (Kolestipol etiketi, İlaç etkileşimleri)

  • Kolestiraminsafra asidi bağlayıcıOrta

    Drug Interactions Cholestyramine for Oral Suspension USP may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic), or propranolol (basic), as well as tetracycline, penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis. (Kolestiramin etiketi, İlaç etkileşimleri)

  • Lantanfosfat bağlayıcıOrta

    Examples of relevant classes of compounds where antacids have been demonstrated to reduce bioavailability include antibiotics (such as quinolones, ampicillin, and tetracyclines), thyroid hormones, ACE inhibitors, statin lipid regulators, and anti-malarials. (Lantan etiketi, İlaç etkileşimleri)

  • Caution should be exercised when JUXTAPID is used with other medications known to have potential for hepatotoxicity, such as isotretinoin, amiodarone, acetaminophen (>4 g/day for ≥3 days/week), methotrexate, tetracyclines, and tamoxifen. (Lomitapid etiketi, Uyarılar ve önlemler)

  • MagnezyumVitamin ve mineralOrta

    Magnezyum içeren takviyeler ve antasitler bu ilaçların emilimini azaltır; dozların arasına en az iki saat koyun. (NIH Office of Dietary Supplements, Magnesium)

  • Pioglitazon ve glimepiridtiyazolidindionOrta

    …antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides,… (Pioglitazon ve glimepirid etiketi, İlaç etkileşimleri)

  • RivaroksabanantikoagülanOrta

    Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Rokuronyumnöromüsküler blokerOrta

    Antibiotics Drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as Rocuronium Bromide Injection include certain antibiotics (e.g., aminoglycosides; vancomycin; tetracyclines; bacitracin; polymyxins; colistin; and sodium colistimethate). (Rokuronyum etiketi, İlaç etkileşimleri)

  • Drug Interactions Some studies have shown that simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of the following: cimetidine, digoxin, fluoroquinolone antibiotics, ketoconazole, l-thyroxine, phenytoin, quinidine, ranitidine, tetracycline, and theophylline. (Sukralfat etiketi, İlaç etkileşimleri)

  • VarfarinantikoagülanOrta

    Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Tetrasiklin etiketi, İlaç etkileşimleri)

Minör değinmeler (26)

  • Antasitler (Tums, Maalox, Mylanta)Reçetesiz ürünMinör

    Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Desogestrel ve etinilestradioloral kontraseptifMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Drospirenon ve etinilestradioloral kontraseptifMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • EstradiolöstrojenMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Estradiol ve dienogestoral kontraseptifMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • FulvestrantöstrojenMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Konjuge östrojenleröstrojenMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • LevonorgestrelprogestinMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Levonorgestrel ve etinilestradioloral kontraseptifMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • MedroksiprogesteronprogestinMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • MegestrolprogestinMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • MifepristonCYP3A4 inhibitörüMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • NoretisteronprogestinMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Noretisteron ve etinilestradioloral kontraseptifMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Norgestimat ve etinilestradioloral kontraseptifMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Norgestrel ve etinilestradioloral kontraseptifMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Omeprazol ve sodyum bikarbonatproton pompası inhibitörüMinör

    Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • ProgesteronprogestinMinör

    Concurrent use of tetracycline may render oral contraceptives less effective. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Sodyum bikarbonatantasitMinör

    Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate. (Tetrasiklin etiketi, İlaç etkileşimleri)

  • Vekuronyumnöromüsküler blokerMinör

    The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (Vekuronyum etiketi, Önlemler)

Anlamlı etkileşim olmadığı bildirilenler (3)

  • AminofilinmetilksantinEtkileşim yok

    …omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinical use are immunoassays which are specific… (Aminofilin etiketi, İlaç etkileşimleri)

  • Sisatrakuryumnöromüsküler blokerEtkileşim yok

    …additional doses of Cisatracurium Besylate Injection, and to determine whether adjustments need to be made to the dose with subsequent administration. † Examples: aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, sodium colistimethate Drug or Drug Class Clinical Implications * Succinylcholine The use of succinylcholine… (Sisatrakuryum etiketi, İlaç etkileşimleri)

  • TeofilinmetilksantinEtkileşim yok

    …ranitidine famotidine rifabutin felodipine roxithromycin finasteride Sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin * Refer to PRECAUTIONS , Drug Interactions for information regarding table. (Teofilin etiketi, İlaç etkileşimleri)

Kullandığınız her şeyi Tetrasiklin ile karşılaştırın. Tüm listenizi ekleyin; her çift tek seferde kontrol edilir.

Sorgulama aracında aç

Tıbbi tavsiye değildir. Şiddet derecesi sizin koşullarınızı değil, etiketin ifadesini yansıtır. “Majör” işareti gözetim altında olağan bir uygulama olabilir, “minör” işareti ise yüksek dozlarda önem kazanabilir. Bir eczacıya danışın.